Safety and immunogenicity of heterologous ChAdOx1-nCoV19 and BNT162b2 vaccination: A meta-analysis of the heterologous COVID-19 vaccination outcomes

Hu, YX; Wang, YN; Shao, TH; Tang, WX; Hu, KR; Zhou, YJ; Miao, LY; Liu, J; Wang, B; Yu, WY

Yu, WY (通讯作者)，China Pharmaceut Univ, Inst Pharmaceut Sci, Nanjing 211198, Peoples R China.;Wang, B (通讯作者)，Nanjing Univ, Affiliated Drum Tower Hosp, Clin Stem Cell Ctr, Med Sch, 321 Zhongshan Rd, Nanjing 210008, Peoples R China.;Liu, J (通讯作者)，Nanjing Yuhua Hosp, Nanjing Hosp 1, Yuhua Branch, Clin Lab, Nanjing 210039, Peoples R China.

VACCINE, 2023; 41 (18): 3003

Abstract

Introduction: Here, we systematically assessed the safety and immunogenicity of the heterologous ChAd/ BNT vaccination regimens.Materials and methods:......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索